Mylan sued for patent infringement over Aubagio

13-01-2017

Mylan sued for patent infringement over Aubagio

Photo courtesy of Mylan

Sanofi and Genzyme have filed a complaint against Mylan for patent infringement over the drug Aubagio (teriflunomide), a treatment for relapsing forms of multiple sclerosis.


Mylan, Sanofi, Genzyme, patent, Aubagio

LSIPR